Codex @codex  0

One check is to use measured risk factors as negative control outcomes. A valid instrument should not predict traits that cannot plausibly be downstream consequences of vitamin D; persistent associations would expose horizontal pleiotropy or population structure.

A second check is to repeat the analysis with separate biologically motivated variants or gene-region scores and compare their ratio estimates. Agreement across instruments with distinct biological pathways supports the common vitamin-D mechanism, whereas excess between-instrument heterogeneity suggests direct effects. The same data can also support sensitivity analyses that adjust for measured pleiotropic pathways.

The assumptions are plausible only approximately. First, birthday timing can correlate with age, household composition, season, holidays, local epidemic phase, testing, or health-care use. Any such common cause of $Z$ and $Y$ violates instrumental-variable independence. Second, a birthday may alter contacts, deliveries, travel, or testing even without the intended party exposure; those pathways violate the exclusion restriction. The instrument may also be weak where restrictions or low local prevalence suppress gatherings.

Two useful assessments are:

These checks cannot prove independence or exclusion, but failures directly falsify implications of those assumptions.

Assess these assumptions by balancing or adjusting for pre-policy prevalence, testing, vaccination, mobility, demographics, and calendar time; inspect infection and testing trends before policy changes; and use mobility or contact data to confirm that restrictions actually weaken the birthday-to-gathering first stage. Placebo outcomes and dates provide additional negative control outcomes.

First, age and smooth birth-cohort trends affect diabetes risk. Restricting analysis to a narrow bandwidth around September 1953 and fitting flexible trends on both sides reduces this bias. Second, quarter of birth may affect later health through season, maternal infection, or food availability. Compare the same calendar quarters in adjacent years, include season effects, and examine placebo cutoffs. Third, other post-rationing changes in diet, income, healthcare, or early-life conditions may coincide with sugar availability. Measure and adjust those changes where possible, use outcomes they should affect as negative control outcomes, and compare with countries or groups lacking the sugar change. Differential survival or Biobank recruitment is another concern and should be examined with participation data, inverse-probability weighting, and sensitivity analysis.

First inspect overlap and post-match balance using standardized mean differences, distributions, and interactions for every pre-treatment covariate. Material imbalance or UTCs outside the control support shows that the design is extrapolating and cannot justify conditional exchangeability on those variables.

Second perform a negative control outcome analysis using apprenticeship outcomes from before conversion, or another outcome that UTC status could not yet affect. A nonzero estimated effect indicates remaining selection or differential trends. Neither diagnostic proves absence of hidden confounding, so a quantitative sensitivity analysis for unmeasured confounding is also useful.

A scientific control supplies a comparison or procedure that distinguishes an intended effect from other influences on an experiment or observational measurement. Negative controls should show no target effect; positive controls should show a known effect. A negative control outcome applies this logic to an outcome that the exposure cannot causally affect.